IGM Biosciences, Inc. Debt Instrument, Fair Value Disclosure
IGM Biosciences, Inc. had Debt Instrument, Fair Value Disclosure of $6.00 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes
us-gaap:DebtInstrumentFairValue · last filed 2022-11-03
- 2022-09-30: Debt Instrument, Fair Value Disclosure $6.00M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2022-09-30 | $6.00M 10-Q · filed 2022-11-03 |